NCT05389371

Brief Summary

Total joint replacement is a highly successful treatment option for people affected by severe osteoarthritis (OA), however, the mismatch between resources and demand for this surgery means that many patients face long wait times while enduring worsening pain and disability. The Alberta Hip and Knee Program is a centralized intake system for patients referred for total joint replacement assessment. Over 3000 patients are assessed annually at the Calgary location (Alberta Hip and Knee Clinic at Gulf Canada Square) where previously patients waited an average of 43 weeks for a surgical consult then an additional 30 weeks until surgery. Given that many elective surgeries in Alberta have been cancelled in response to the COVID19 pandemic, these wait times have increased significantly, with no clearing of the surgical backlog for the foreseeable future. Long wait times for patients can become a spiral of more debility, less mobility, and subsequent weight gain. The current standard of care for patients with obesity awaiting surgery provides little support or guidance beyond general advice about the importance of a healthy weight and remaining active. This waiting period represents an untapped window of opportunity to intervene and help patients with obesity and OA to lessen their disease burden and improve overall health, while addressing patient priorities such as regaining lost function and improving quality of life. Many patients with osteoarthritis also have obesity. The best practices in obesity treatment requires a multidisciplinary approach. Our aim is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility of incorporating the multidisciplinary Alberta Obesity Centre program into the clinical care pathway for patients with obesity and OA while they await surgical evaluation at the Alberta Hip and Knee Clinic at Gulf Canada Square. The results of this feasibility trial will help inform a larger scale trial that will be powered for clinical and health economics outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jun 2022

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

June 28, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

May 22, 2024

Status Verified

November 1, 2023

Enrollment Period

2.2 years

First QC Date

May 19, 2022

Last Update Submit

May 20, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Determine the number of adults with osteoarthritis and obesity that are eligible to participate in the trial

    The number of patients approached

    0-12 months

  • The number of these adults with osteoarthritis and obesity who would be willing to take part in this trial

    The number of patients who actually enroll

    0-12 months

  • The characteristics of these adults with osteoarthritis and obesity who are willing to take part in the trial

    Patient sex, gender, age, and medical history

    0-12 months

  • The number and percentage of participants retained at 12-months

    Number and percentage of patients attending at 12-month follow up and reasons for drop-out

    0-12 months

Secondary Outcomes (8)

  • Change in body mass

    0-12 months

  • Decision to proceed with joint replacement surgery

    12 months

  • Change in waist circumference

    0-12 months

  • Change in blood pressure

    0-12 months

  • Change in blood lipid profile

    0-12 months

  • +3 more secondary outcomes

Study Arms (2)

Alberta Healthy Living Program

ACTIVE COMPARATOR

An integrated community-based chronic disease management program available to residents of Alberta.

Behavioral: Alberta Healthy Living ProgramBehavioral: Osteoarthritis adviceBehavioral: Physiotherapy

Alberta Obesity Centre Program

EXPERIMENTAL

Evidence-based medical management of obesity using a multidisciplinary approach.

Behavioral: Alberta Obesity Centre ProgramBehavioral: Osteoarthritis adviceBehavioral: Physiotherapy

Interventions

Weight management services

Alberta Healthy Living Program

Multi-disciplinary obesity management

Alberta Obesity Centre Program

Living Your Best Life with Osteoarthritis Handbook

Alberta Healthy Living ProgramAlberta Obesity Centre Program
PhysiotherapyBEHAVIORAL

GLA:D physiotherapy programs.

Also known as: GLA:D (TM) education and exercise
Alberta Healthy Living ProgramAlberta Obesity Centre Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • body mass index (weight in kilograms divided by height in metres squared) greater than 30
  • symptomatic osteoarthritis (referred to the Alberta Hip and Knee Clinic for assessment for total joint replacement surgery)

You may not qualify if:

  • Currently following a specialized or therapeutic diet
  • pregnant or breastfeeding
  • diagnosed with type 1 diabetes
  • unable to read or speak English
  • unable to use email
  • unable to use virtual platforms such as Zoom

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Calgary

Calgary, Alberta, T2N 1N4, Canada

Location

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritis, HipOsteoarthritis

Interventions

Physical Therapy ModalitiesEducational StatusExercise

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationSocioeconomic FactorsPopulation CharacteristicsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: parallel-arm randomized trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2022

First Posted

May 25, 2022

Study Start

June 28, 2022

Primary Completion

August 31, 2024

Study Completion

September 30, 2025

Last Updated

May 22, 2024

Record last verified: 2023-11

Locations